Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SanDisk (SNDK) vs Veeva Systems (VEEV) Price & Performance

Veeva SystemsTrade

Price performance (Past 24H)

Key statistics

SanDisk vs Veeva Systems — how do they compare? SanDisk trades at $1,762.38 (market cap $254.47B), while Veeva Systems trades at $260.88 (market cap $42.88B). The key difference: SanDisk is far larger — about 5.9× Veeva Systems's market cap. Which is the better fit depends on your goals.

SNDKVEEV
Market Cap
$254.47B$42.88B
Sector
TechnologyTechnology
52-Week High
$2.34K$306.22
52-Week Low
$73.92$151.43
Enterprise Value
$249.89B$35.79B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SanDisk

SNDK trades at $1,737.99, down 0.12% on the day, with a neutral technical signal. The stock has surged over 500% in 2026, driven by AI-driven memory demand, and is set to join the S&P 500. Recent quarters show strong EPS beats, with Q2 2026 actual EPS of $39.25 surpassing the $34.96 estimate. Fundamentals are mixed, with a net loss in 2025 but a projected profit margin of 56.46% for 2026, supported by high gross margins and robust ROE of 91.64%.

Outlook is bullish due to AI memory supercycle tailwinds and contracted revenue floors, but risks include volatility from insider selling and valuation concerns. Analysts are overwhelmingly positive, with 87.5% buy ratings and a consensus price target of $2,330, implying 34% upside. Investors should weigh high growth potential against execution risks in a cyclical sector.

Veeva Systems

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About SanDisk

Sandisk is a semiconductor memory company specializing in NAND flash technology. Its storage products support consumer devices, enterprise systems, and cloud and AI infrastructure.

Read more on SNDK

About Veeva Systems

Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.

Read more on VEEV